Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;90:139-147

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, J. A.
Right arrow Articles by Corr, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, J. A.
Right arrow Articles by Corr, P. B.

Circulation, Vol 90, 139-147, Copyright © 1994 by American Heart Association


ARTICLES

Arrhythmogenic influence of intracoronary thrombosis during acute myocardial ischemia

JA Goldstein, MC Butterfield, Y Ohnishi, TJ Shelton and PB Corr
Department of Medicine, Washington University School of Medicine, St Louis, MO 63198.

BACKGROUND: Patients with acute coronary artery thrombosis often develop primary malignant ventricular arrhythmias (MVA) early after coronary occlusion. In contrast, acute ischemia induced by nonthrombotic balloon occlusion during routine coronary angioplasty rarely elicits such arrhythmias. This study was designed to assess the role of intracoronary thrombosis in arrhythmogenesis during acute ischemia. METHODS AND RESULTS: We compared the incidence of MVA associated with acute left anterior descending coronary artery (LAD) thrombosis elicited in open-chest anesthetized dogs by electrical injury (n = 10) or intracoronary stent (n = 9) versus LAD balloon occlusion (n = 15). Compared with animals subjected to balloon occlusion, those with thrombotic occlusion had a significantly greater incidence of MVA, defined as nonsustained ventricular tachycardia (total duration > 10 seconds), sustained ventricular tachycardia, or ventricular fibrillation developing within the first 30 minutes of occlusion. In the combined thrombosis groups, MVA developed in 11 of 19 animals (58%) (6 of 10 dogs with electrical injury and 5 of 9 stent animals). In contrast, MVA occurred in only 1 of 15 animals (7%) subjected to balloon occlusion. This striking and significant difference in arrhythmias occurred despite the fact that radioactive microsphere perfusion analysis documented that the extent of left ventricular myocardium rendered ischemic was equal in all groups (percent of left ventricular myocardium with occlusion flow < or = 50% of baseline: electrical injury, 25.2 +/- 5.3%; stent, 27.1 +/- 3.6%; balloon, 34.3 +/- 11.6%; P = NS). Furthermore, there were no differences between the animals with thrombosis or balloon occlusion with respect to changes in echocardiographic parameters of left ventricular function, aortic pressure, or heart rate after occlusion. CONCLUSIONS: These data provide evidence that despite equal magnitudes of jeopardized myocardial mass, acute ischemia induced by thrombotic coronary occlusion results in a greater incidence of MVA than does nonthrombotic balloon occlusion. These findings suggest that the process of intracoronary thrombosis itself exerts arrhythmogenic effects above and beyond the impact of ischemia on myocardium induced by coronary occlusion.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Pinet, V. Algalarrondo, S. Sablayrolles, B. Le Grand, C. Pignier, D. Cussac, M. Perez, S. N. Hatem, and A. Coulombe
Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes
Mol. Pharmacol., June 1, 2008; 73(6): 1622 - 1631.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Pinet, B. Le Grand, G. W. John, and A. Coulombe
Thrombin Facilitation of Voltage-Gated Sodium Channel Activation in Human Cardiomyocytes: Implications for Ischemic Sodium Loading
Circulation, October 15, 2002; 106(16): 2098 - 2103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. McHowat and M. H. Creer
Selective plasmalogen substrate utilization by thrombin-stimulated Ca2+-independent PLA2 in cardiomyocytes
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1933 - H1940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Landau, R. Tirosh, A. Pinson, S. Banai, S. Even-Ram, M. Maoz, S. Katzav, and R. Bar-Shavit
Protection of Thrombin Receptor Expression under Hypoxia
J. Biol. Chem., January 28, 2000; 275(4): 2281 - 2287.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. A. Woodcock, N. Reyes, A. N. Jacobsen, and X.-J. Du
Inhibition of Inositol(1,4,5)Trisphosphate Generation by Endothelin-1 During Postischemic Reperfusion : A Novel Antiarrhythmic Mechanism
Circulation, February 16, 1999; 99(6): 823 - 828.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. H. Creer and J. McHowat
Selective hydrolysis of plasmalogens in endothelial cells following thrombin stimulation
Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1498 - C1507.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A Woodcock, S. J Matkovich, and O. Binah
Ins(1,4,5)P3 and cardiac dysfunction
Cardiovasc Res, November 1, 1998; 40(2): 251 - 256.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Hasenfuss
Animal models of human cardiovascular disease, heart failure and hypertrophy
Cardiovasc Res, July 1, 1998; 39(1): 60 - 76.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. McHowat and M. H. Creer
Thrombin activates a membrane-associated calcium-independent PLA2 in ventricular myocytes
Am J Physiol Cell Physiol, February 1, 1998; 274(2): C447 - C454.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Coronel, F. J. G. Wilms-Schopman, and M. J. Janse
Profibrillatory Effects of Intracoronary Thrombus in Acute Regional Ischemia of the In Situ Porcine Heart
Circulation, December 2, 1997; 96(11): 3985 - 3991.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Wu and W. T. Clusin
Calcium transient alternans in blood-perfused ischemic hearts: observations with fluorescent indicator Fura Red
Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2161 - H2169.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. F. Borges, P. K. Spohn, and A. S. Coulson
Arrhythmia/Ischemia Management During Minimally Invasive Cardiac Operation
Ann. Thorac. Surg., September 1, 1997; 64(3): 843 - 844.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. Yasutake, R. S. Haworth, A. King, and M. Avkiran
Thrombin Activates the Sarcolemmal Na+-H+ Exchanger: Evidence for a Receptor-Mediated Mechanism Involving Protein Kinase C
Circ. Res., October 1, 1996; 79(4): 705 - 715.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
T. Jiang, V. Kuznetsov, E. Pak, H. Zhang, R. B. Robinson, and S. F. Steinberg
Thrombin Receptor Actions in Neonatal Rat Ventricular Myocytes
Circ. Res., April 1, 1996; 78(4): 553 - 563.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Ohnishi, M. C. Butterfield, J. E. Saffitz, B. E. Sobel, P. B. Corr, and J. A. Goldstein
Deleterious Effects of a Systemic Lytic State on Reperfused Myocardium : Minimization of Reperfusion Injury and Enhanced Recovery of Myocardial Function by Direct Angioplasty
Circulation, August 1, 1995; 92(3): 500 - 510.
[Abstract] [Full Text]


Home page
CirculationHome page
X.-J. Du, K. E. Anderson, A. Jacobsen, E. A. Woodcock, and A. M. Dart
Suppression of Ventricular Arrhythmias During Ischemia-Reperfusion by Agents Inhibiting Ins(1,4,5)P3 Release
Circulation, June 1, 1995; 91(11): 2712 - 2716.
[Abstract] [Full Text]